Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Deurion is a private Seattle-based life sciences tools company developing hardware and software for mass spectrometry applications. Its core technology combines digital microfluidics with surface acoustic wave nebulization to create a lab-on-a-chip interface for sample preparation and ionization into mass spectrometers. The company appears to be focused on research-use and translational applications rather than commercial therapeutics, with work spanning biological mass spectrometry, bioinformatics, and microfluidics. Publicly visible grant records indicate programs in high-throughput SAWN ion sources, DMF-SAWN biomedical workflows, and computational feature-learning methods for multiplex disease diagnosis. Deurion therefore fits best as a healthcare-adjacent bioanalytical instrumentation/platform company rather than a drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Deurion.